Idarubicin

Chemical formula: C₂₆H₂₇NO₉  Molecular mass: 497.494 g/mol  PubChem compound: 42890

Active ingredient description

Idarubicin is a DNA intercalating anthracycline which interacts with the enzyme topoisomerase II and has an inhibitory effect on nucleic acid synthesis. Idarubicin has been shown to have a higher potency with respect to daunorubicin and to be an effective agent against murine leukaemia and lymphomas both by i.v. and oral routes.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code Group title Classification
L01DB06 Idarubicin L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01D Cytotoxic antibiotics and related substances → L01DB Anthracyclines and related substances
Discover more medicines within L01DB06

Product monographs

Competent medicine agencies globally have authorized commercialization of this active ingredient according to these medication package inserts (MPIs):

Title Information Source Document Type  
ZAVEDOS Powder for solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
ZAVEDOS Capsules Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC

Structural formula

Graphic representation of the active ingredient's molecular structure

External identifiers

CAS Substance: 57852-57-0
CAS Substance: 58957-92-9
DrugBank Drug: DB01177
PubChem Compound: 42890
RxNorm Ingredient: 5650
SNOMED-CT Concept: 372539000
Idarubicin (substance)
UNII Identifier: ZRP63D75JW
IDARUBICIN

Medicines

Idarubicin is an active ingredient of these brands:

United States (US)

Australia (AU)

  • ZAVEDOS as IDARUBICIN HYDROCHLORIDE

Austria (AT)

  • ZAVEDOS as IDARUBICIN HYDROCHLORIDE

Brazil (BR)

  • EVOMID as IDARUBICIN HYDROCHLORIDE
  • ZAVEDOS as IDARUBICIN HYDROCHLORIDE

Croatia (HR)

  • ZAVEDOS as IDARUBICIN HYDROCHLORIDE

Cyprus (CY)

  • ZAVEDOS as IDARUBICIN HYDROCHLORIDE

Ecuador (EC)

  • ZAVEDOS as IDARUBICIN HYDROCHLORIDE

Estonia (EE)

  • ZAVEDOS as IDARUBICIN HYDROCHLORIDE

Finland (FI)

  • ZAVEDOS as IDARUBICIN HYDROCHLORIDE

France (FR)

  • ZAVEDOS as IDARUBICIN HYDROCHLORIDE

Hong Kong (HK)

  • ZAVEDOS as IDARUBICIN HYDROCHLORIDE

Ireland (IE)

  • ZAVEDOS as IDARUBICIN HYDROCHLORIDE

Israel (IL)

  • ZAVEDOS as IDARUBICIN HYDROCHLORIDE

Japan (JP)

Lithuania (LT)

  • ZAVEDOS as IDARUBICIN HYDROCHLORIDE

Malta (MT)

  • ZAVEDOS as IDARUBICIN HYDROCHLORIDE

Mexico (MX)

Netherlands (NL)

  • ZAVEDOS as IDARUBICIN HYDROCHLORIDE

New Zealand (NZ)

  • ZAVEDOS as IDARUBICIN HYDROCHLORIDE

Poland (PL)

  • ZAVEDOS as IDARUBICIN HYDROCHLORIDE

Romania (RO)

  • ZAVEDOS as IDARUBICIN HYDROCHLORIDE

Singapore (SG)

  • ZAVEDOS as IDARUBICIN HYDROCHLORIDE

South Africa (ZA)

  • ZAVEDOS as IDARUBICIN HYDROCHLORIDE

Spain (ES)

  • ZAVEDOS as IDARUBICIN HYDROCHLORIDE

Tunisia (TN)

  • ZAVEDOS as IDARUBICIN HYDROCHLORIDE

Turkey (TR)

  • IDAMEN as IDARUBICIN HYDROCHLORIDE
  • IDARUB as IDARUBICIN HYDROCHLORIDE
  • ZADOSS as IDARUBICIN HYDROCHLORIDE
  • ZAVEDOS as IDARUBICIN HYDROCHLORIDE

United Kingdom (UK)

  • ZAVEDOS as IDARUBICIN HYDROCHLORIDE

Note the following: The list of brand names is continuously updated, and thus does not include the total of products circulating worldwide.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.